Is it safe to take NSAIDs (Non-Steroidal Anti-Inflammatory Drugs) after PRP (Platelet-Rich Plasma) therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

NSAIDs After PRP Therapy: Timing and Safety

You should avoid taking NSAIDs for at least 7 days before PRP injection, not after it—taking NSAIDs after day 20 post-PRP is generally safe and will not interfere with the healing process.

Understanding the Critical Window

The concern about NSAIDs and PRP relates to the pre-treatment period, not the post-treatment period. NSAIDs inhibit cyclooxygenase-1 (COX-1), which blocks platelet degranulation—the very process that releases growth factors from PRP to promote healing 1.

Pre-PRP NSAID Deferral Guidelines

Different NSAIDs require different washout periods before PRP:

  • Naproxen: Defer for 48 hours minimum (platelet inhibition lasts at least 24-48 hours) 1
  • Indomethacin: Defer for 24 hours (recovery occurs by 24 hours) 1
  • Ibuprofen and Diclofenac: Defer for 12-24 hours depending on dose (inhibition lasts 6-12 hours) 1
  • Acetaminophen: No deferral needed (mild COX-1 inhibitor with no clinically significant platelet effects) 1

Post-PRP NSAID Use (Your Situation)

Taking NSAIDs on day 20 after PRP is safe because:

  • The critical platelet degranulation and growth factor release occurs within the first 7-10 days after PRP injection 1
  • By day 20, the initial healing cascade triggered by PRP has already been established
  • One animal study showed no negative interaction between PRP and indomethacin when given post-procedure, with PRP-treated tendons maintaining superior biomechanical strength regardless of NSAID use 2

Important Safety Considerations for Your 7-Day NSAID Course

While the timing relative to PRP is acceptable, you must consider standard NSAID safety precautions:

Gastrointestinal Risk

  • Use the lowest effective dose for the shortest duration (your 7-day course is appropriately short) 3, 4
  • If you have history of GI bleeding or ulcers, you need proton pump inhibitor (PPI) co-therapy 3
  • Avoid combining with aspirin, as this increases GI bleeding risk 2-5 fold 3

Cardiovascular Risk

  • NSAIDs can increase blood pressure by approximately 5 mm Hg 4, 5
  • If you're on blood pressure medications (especially ACE inhibitors or ARBs), monitor your blood pressure during the NSAID course 3, 4
  • Avoid NSAIDs if you have congestive heart failure 4, 5

Renal Risk

  • NSAIDs should be avoided if you have pre-existing kidney disease 3
  • Approximately 2% of NSAID users develop renal complications requiring discontinuation 3, 4
  • Risk increases if you're taking ACE inhibitors, ARBs, or diuretics 3

Anticoagulant Interactions

  • If you're on blood thinners (warfarin, apixaban, rivaroxaban), NSAIDs increase bleeding risk 3-6 fold 3, 5
  • This combination requires PPI prophylaxis and close monitoring 5
  • Consider acetaminophen instead if you're anticoagulated 5

Clinical Bottom Line

Your physician's instruction to take a 7-day NSAID course starting on day 20 post-PRP is medically sound from a PRP-efficacy standpoint. The PRP has already done its job by day 20. However, ensure you don't have contraindications to NSAIDs themselves (active ulcer, severe kidney disease, heart failure, or high-risk anticoagulation) 3, 4.

References

Research

Effects of Platelet-Rich Plasma and Indomethacin on Biomechanics of Rotator Cuff Repair.

American journal of orthopedics (Belle Mead, N.J.), 2017

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Concurrent Use of Losartan and NSAIDs: Safety Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Concurrent Use of NSAIDs with Eliquis (Apixaban)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.